Target intelligence / Profile preview

NmrA-like family domain-containing protein 1 (NMRAL1)

Target
NMRAL1
Molecular classification
Redox sensor protein, NmrA-like protein, Short-chain dehydrogenase/reductase (SDR) superfamily (non-enzymatic, catalytically inactive)
01

Overview

NmrA-like family domain-containing protein 1 (NMRAL1, also known as HSCARG or SDR48A1) is a redox sensor protein widely conserved in mammals and other higher animals[1][5]. It contains a Rossmann fold and is structurally similar to, but functionally distinct from, enzymatic short-chain dehydrogenases/reductases (SDR): it binds NADPH selectively but does not catalyze metabolic reactions due to a lack of key catalytic residues[1]. NMRAL1/HSCARG acts as an intracellular NADPH sensor, existing primarily as a dimer under normal reducing conditions and as a monomer when NADPH levels fall, at which point it interacts with partners such as argininosuccinate synthase (ASS1), inhibiting nitric oxide production and modulating the immune response[2][5]. It negatively regulates the NF-κB and RLR innate immune signaling pathways, modulates cellular redox balance by suppressing ROS and NO production, and, during oxidative stress, relocates to the nucleus to influence the DNA damage response[1][3][5]. Although identified as playing roles in several disease contexts (notably some corneal dystrophies and possibly cancer and immune disorders), NMRAL1 is not currently considered a direct therapeutic target, and no drugs are known to act specifically on it[2][5].

Other names
HSCARGSDR48A1NmrA-like redox sensor 1FLJ25918short chain dehydrogenase/reductase family 48A member 1nmrA-like family domain containing 1
02

Biological functions

Redox homeostasisRegulation of innate immunity (NF-κB and RLR signaling)Suppression of reactive oxygen species (ROS) and nitric oxide (NO) generationRegulation of DNA damage responseCellular response to oxidative stress
03

Disease associations

Corneal dystrophies (granular, lattice, macular, endothelial)SchizophreniaAnemia, congenital, nonspherocytic hemolyticPotential linkage to cancer, inflammation, and antiviral responses

Beyond the preview

Go deeper on NmrA-like family domain-containing protein 1 (NMRAL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NmrA-like family domain-containing protein 1 (NMRAL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call